Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Virus Vaccine”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04695717
What this trial is testing

This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam

Who this might be right for
Influenza
Vietnam Military Medical University 864
Early research (Phase 1)Study completedNCT05968989
What this trial is testing

Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 30
Testing effectiveness (Phase 2)Study completedNCT00644540
What this trial is testing

Immunogenicity and Safety Following a Single Dose of Influenza Vaccines in Healthy Children Who Received Either One or the Other Vaccine (an Adjuvanted Sub-unit Influenza Vaccine and a Non-adjuvanted Split Virion Influenza Vaccine) in the Previous V70P2 Study

Who this might be right for
FLU
Novartis Vaccines 89
Large-scale testing (Phase 3)Study completedNCT02387294
What this trial is testing

Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents

Who this might be right for
Human Influenza
Fluart Innovative Vaccine Ltd, Hungary 120
Large-scale testing (Phase 3)Study completedNCT01481454
What this trial is testing

Study of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and Adults

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 1,701
Early research (Phase 1)Study completedNCT00380237
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 20
Post-approval studies (Phase 4)Ended earlyNCT01690637
What this trial is testing

Panama and El Salvador Children's Oseltamivir Study

Who this might be right for
InfluenzaHuman Influenza
Centers for Disease Control and Prevention 721
Large-scale testing (Phase 3)Ended earlyNCT01014091
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of GSK Biological Pandemic Candidate Influenza Vaccine (H1N1) in Children

Who this might be right for
Influenza
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Study completedNCT02921997
What this trial is testing

H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses

Who this might be right for
Avian InfluenzaH1N1 InfluenzaInfluenza
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT02330003
What this trial is testing

Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer

Who this might be right for
Healthy
Il-Yang Pharm. Co., Ltd. 100
Post-approval studies (Phase 4)Study completedNCT01457027
What this trial is testing

Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza Season

Who this might be right for
Influenza
Crucell Holland BV 52
Not applicableStudy completedNCT01286142
What this trial is testing

Oseltamivir Infant Influenza Safety Study

Who this might be right for
Influenza, Human
Charite University, Berlin, Germany 900
Not applicableStudy completedNCT02067286
What this trial is testing

Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer

Who this might be right for
Influenza AInfluenza BRespiratory Syncytial Virus (RSV)
IQuum, Inc. 1,642
Testing effectiveness (Phase 2)Study completedNCT00283283
What this trial is testing

Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine

Who this might be right for
Influenza
U.S. Army Medical Research and Development Command 1,316
Early research (Phase 1)Study completedNCT00727428
What this trial is testing

Immunogenicity and Safety of GSK Biologicals' FluLaval® TF

Who this might be right for
Influenza
GlaxoSmithKline 110
Testing effectiveness (Phase 2)Study completedNCT02071914
What this trial is testing

Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model

Who this might be right for
Influenza A
Celltrion 81
Testing effectiveness (Phase 2)Study completedNCT00376402
What this trial is testing

Study of a Pandemic Influenza Vaccine in Elderly Participants

Who this might be right for
Influenza
Seqirus 200
Post-approval studies (Phase 4)Study completedNCT03023553
What this trial is testing

The Human Mucosal Immune Responses to Influenza Virus (SLVP026)

Who this might be right for
Influenza
Stanford University 13
Large-scale testing (Phase 3)Study completedNCT00391053
What this trial is testing

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Who this might be right for
Orthomyxoviridae InfectionInfluenzaMyxovirus Infection
Sanofi Pasteur, a Sanofi Company 3,851
Large-scale testing (Phase 3)Study completedNCT00240877
What this trial is testing

Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)

Who this might be right for
Influenza
MedImmune LLC 330
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation